Correlation between HIV sequence evolution, specific immune response and clinical outcome in vertically infected infants

AIDS

Volumn 11, Issue 14, 1997, Pages 1709-1717

  Halapi, Eva ^a,b   Leitner, Thomas ^c   Jansson, Marianne ^a,b   Scarlatti, Gabriella ^d   Orlandi, Paola ^b   Plebani, Anna ^d   Romiti, Luisa ^b   Albert, Jan ^c   Wigzell, Hans ^a   Rossi, Paolo ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Disease progression; Genetic variability; gp120 V3 region; Paediatric HIV 1 infection

Indexed keywords

GLYCOPROTEIN GP 120; VIRUS DNA;

ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE COURSE; DNA SEQUENCE; GENETIC DISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFANT; MOLECULAR CLONING; MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; VIRUS IMMUNITY;

AMINO ACID SEQUENCE; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE PROGRESSION; DISEASE TRANSMISSION, VERTICAL; EVOLUTION, MOLECULAR; HIV ANTIBODIES; HIV ANTIGENS; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MOLECULAR SEQUENCE DATA; PEPTIDE BIOSYNTHESIS; PEPTIDE FRAGMENTS; PHYLOGENY; PROSPECTIVE STUDIES;

EID: 9844229369     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199714000-00007     Document Type: Article

References (55)

1. Alizon M, Wain-Hobson S, Montagnier L, Sonigo P: Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell 1986, 46:63-74
2. Hahn BH, Gonda MA, Shaw GM, Popovics M, Hoxie JA, Gallo RC: Genomic diversity of the acquired immnodeficiency virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes. Proc Natl Acad Sci USA 1985, 82:4813-4817.
3. Saag MS, Hahn BH, Gibbons J, et al.: Extensive variation of human immunodeficiency virus type-1 in vivo. Nature 1988, 334:440-444.
4. Shpaer EG, Mullins JI: Rates of amino acid change in the enveS lope protein correlate with pathogenicity of primate lentiviruses. J Mol Evol 1993, 37:57-65.
5. Wolinsky SM, Wike GM, Korber BT, et al.: Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992, 255:1134-1137.
6. Zhu T, Mo H, Wang N, et al.: Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993, 261:1179-1181.
7. Scarlatti G, Leitner T, Halapi E, et al.: Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. Proc Natl Acad Sci USA 1993, 90:1721-1725.
8. Dougherty JP, Temin HM: Determination of of the rate of base-pair substitution and insertion mutation in retrovirus replication. Biotechnology 1991, 16:21-33.
9. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
10. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR: Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991, 253:71 74.
11. McKeating JA, Gow I, Goudsmil J, Pearl LH, Mulder C, Weiss RA: Characterization of HIV-1 neutralization escape mutants. AIDS 1989, 3:777 784.
12. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD: HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996, 271:1582-1586.
13. Watkins BA, Reitz Jr MS, Wilson CA, Aldrich K, Davis AE, Rohert-Guroff M: Immune escape by human immunodeficiency virus type 1 from neutralizing antibodies: evidence for multiple pathways. J Virol 1993, 67:7493-7500.
14. Wei X, Ghosh SK, Taylor ME, et al.: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995, 373:117-122.
15. Mansky LM, Termin HM: Lower in vivo mutation rate of human immunodeficiency virus type 1 than predicted from the fidelity of purified reverse transcriptase. J Virol 1995, 69:5087-5094.
16. Coffin JM: HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995, 267:483-489.
17. Gojobori I, Moriyama LN, Kimura M: Molecular clock of viral evolution, and the neutral theory. Proc Natl Acad Sci USA 1990, 87:10015-10018.
18. Blanche S, Tardieu M, Duliege A, et al.: Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Am J Dis Child 1990, 144:1210-1215.
19. Italian Register for HIV Infection in Children: Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet 1994, 343:191-195.
20. The European Collaborative Study: Natural history of vertically acquired human immunodeficency virus-1 infection. Pediatrics 1994, 94:815-819.
21. Tovo PA, de Martino M, Gabiano C, et al.: Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections in Children. Lancet 1992, 339:1249-1253.
22. Galli L, de Martino M, Tovo P-A, et al.: Onset of clinical signs in children with HIV-1 perinatal infection. AIDS 1995, 9:455-461.
23. De Rossi A, Giaquinto C, Omotto L, et al.: Replication and tropism of human immunodeficiency virus type 1 as predictors of disease outcome in infants with vertically acquired infection. J Pediatr 1993, 123:929-936.
24. De Rossi A, Ometto L, Zanotto C, et al.: Mother-to-child HIV-1 transmission: quantitative assessment of viral burden as a diagnostic tool and prognostic parameter in HIV-1-infected children. Acta Paediatr Suppl 1994, 400:25-28.
25. Dickover RE, Dillon M, Gillette SG, et al.: Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infanls. J Infect Dis 1994, 170:1279-1284.
26. Palumbo PE, Kwok S, Waters S, et al.: Viral measurement by polymerase chain reaction-based assays in human immunodeficiency virus-infected infants. J Pediatr 1995, 126:592-595.
27. Centers for Disease Control: 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994, 43:1-10.
28. Albert J, Fenyö EM: Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primer. J Clin Microbiol 1990, 28:1560-1564.
29. Hultman T, Stahl S, Hornes E, Uhlen M: Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acids Res 1989, 17:49.57-4946.
30. Smith SW, Overbcek R, Woese CR, Gilbert W, Gilbert PM: The genetic data environment: an expandable GUI for multiple sequence analysis. Comput Appl Biosci 1994, 10:671-675.
31. Jukes TH, Cantor CR: Evolution of protein molecules. In Mammalian Protein Metabolism. Edited by Munro HN. New York: Academic Press; 1969:21-132.
32. Felsenstein J: Phylogenetic Interference Package. University of Washington, Seattle 1993.
33. Swofford DL: PAUP: Phylogenetic Analysis Using Parsimony 3.1.1 Ed. Illinois Natural Survey Campain; 1991.
34. Nei M, Gojobori T. Simple methods for estimating the numbers of synonymous and non-synonymous nucleotide substitutions. Mol Biol Evol 1986, 3:418-426.
35. Kumar S, Tamura K, Nei M: MEGA; Molecular Evolutionary Genetic Analysis 1.01 Ed. The Pennsylvania State University: 1993
36. Sallberg M, Ruden U, Magnius LO, Norrby E, Wahren B: Rapid "tea-bag" peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins. Immunol Lett 1991, 30:59-68.
37. Strunnikova N, Ray SC, Livingston RA, Rubalcaba E, Viscidi RP: Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression. J Virol 1995, 69:7548-7558.
38. Wolfs TF, de Jong JJ, Van den Berg H, Tijnagel IM, Krone WJ, Goudsmit J: Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous. Proc Natl Acad Sci USA 1990, 87:9938-9942.
39. Albert J, Wahlberg J, Leitner T, Escanilla D, Uhlén M: Analysis of a rape case by direct sequencing of the HIV-1 pol and gag genes. J Virol 1994, 68:5918-5924.
40. Ou CY, Ciesielski CA, Myers G, et al.: Molecular epidemiology of HIV transmission in a dental practice. Science 1992, 256:1165-1171.
41. Lamers SL, Sleasman JW, She JX, et al.: Persistence of multiple maternal genotypes of human immunodeficiency virus type 1 in infants infected by vertical transmission. J Clin Invest 1994, 93:380-390.
42. Ganeshan S, Dickover RE, Korber BTM, Bryson, YJ, Wolinsky, SM: Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease. J Virol 1997, 71:663-667.
43. Delwart EL, Sheppard HW, Walker BD, Goudsmit J, Mullins JI: Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J Virol 1994, 68:6672-6683.
44. Lukashov VV, Kuiken CL, Goudsmit J: Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period. J Virol 1995, 69:6911-6916.
45. Bonhoeffer S, Holmes EC, Nowak MA: Causes of HIV diversity [letter]. Nature 1995, 376:125.
46. Wolinsky SM, Korber BTM, Neumann AU, et al.: Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 1996, 272:537-542.
47. McDonald RA, Mayers DL, Chung RC, et al.: Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disese progression and T-cell function. J Virol 1997, 71: 1871-1879.
48. Burns DP, Desrosiers RC: Envelope sequence variation, neutralizing antibodies, and primate lentivirus persistence. Curr Topics Microb Immunol 1994, 188:185-219.
49. Fitch WA, Leiter JME, Li X, Palese P: Positive Darwinian evolution in human influenza A viruses. Proc Natl Acad Sci USA 1991, 88:4270-4272.
50. Leigh Brown A, Monaghan P: Evolution of the structural proteins of human immunodeficiency virus: selective constraint on nucleotide substitutions. AIDS Res Hum Retroviruses 1988, 4:399-407.
51. De long JJ, De Ronde A, Keulen W, Tersmette M, Goudsmit J: Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J Virol 1992, 66:6777-6780.
52. Chesebro B, Wehrly K, Nishio J, Perryman S: Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol 1992, 66:6547-6554
53. Fourchier RAM, Groenink NA, Koostra NA, et al.: Phenotype associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp 120 molecule. J Virol 1992, 66:3183-3187.
54. Tersmette M, de Goede RE, Winkel BJ, et al.: Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol 1988, 62:2026-2032.
55. Schuitemaker H, Koot M, Koostra NA, et al.: Biological phenotype of human immunodeficiency virus type 1 clones at different stage of infection: progression to disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 1992, 66:1354-1360.